_version_ 1798025296205578240
author Laetitia Fend
Eric Quemeneur
Monika Semmrich
Jean-Baptiste Marchand
Matilda Rehn
Nathalie Silvestre
Linda Mårtensson
Johann Foloppe
Ingrid Teige
Björn Frendeus
Petra Holmkvist
Carolin Svensson
Christelle Remy
Patricia Kleinpeter
Jules Deforges
Fred Junghus
Kirstie L Cleary
Mimoza Bodén
author_facet Laetitia Fend
Eric Quemeneur
Monika Semmrich
Jean-Baptiste Marchand
Matilda Rehn
Nathalie Silvestre
Linda Mårtensson
Johann Foloppe
Ingrid Teige
Björn Frendeus
Petra Holmkvist
Carolin Svensson
Christelle Remy
Patricia Kleinpeter
Jules Deforges
Fred Junghus
Kirstie L Cleary
Mimoza Bodén
author_sort Laetitia Fend
collection DOAJ
first_indexed 2024-04-11T18:16:19Z
format Article
id doaj.art-715bfd92355a4c01a650b6be33e6abb9
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-04-11T18:16:19Z
publishDate 2022-01-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-715bfd92355a4c01a650b6be33e6abb92022-12-22T04:09:53ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262022-01-0110110.1136/jitc-2021-003488Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumorsLaetitia Fend0Eric Quemeneur1Monika Semmrich2Jean-Baptiste Marchand3Matilda Rehn4Nathalie Silvestre5Linda Mårtensson6Johann Foloppe7Ingrid Teige8Björn Frendeus9Petra Holmkvist10Carolin Svensson11Christelle Remy12Patricia Kleinpeter13Jules Deforges14Fred Junghus15Kirstie L Cleary16Mimoza Bodén17Aff1 grid.420228.e0000 0004 0638 2273Transgene FranceAff4 grid.420228.e0000000406382273Transgene SA Parc d’Innovation, CS80166 67405 Illkirch-Graffenstaden Cedex FrancePreclinical Research, BioInvent International AB, Lund, Sweden2Transgene SA, Illkirch Graffenstaden, France1BioInvent International AB, Lund, Sweden2Transgene SA, Illkirch Graffenstaden, FrancePreclinical Research, BioInvent International AB, Lund, Sweden2Transgene SA, Illkirch Graffenstaden, FrancePreclinical Research, BioInvent International AB, Lund, Sweden1BioInvent International AB, Lund, SwedenBiInvent International, Lund, SwedenBiInvent International, Lund, SwedenDepartment of Research, Transgene SA, Illkirch-Graffenstaden, FranceDepartment of Research, Transgene SA, Illkirch-Graffenstaden, FranceDepartment of Research, Transgene SA, Illkirch-Graffenstaden, FranceDepartment of Research, BioInvent International AB, Lund, SwedenAntibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UKDepartment of Research, BioInvent International AB, Lund, Swedenhttps://jitc.bmj.com/content/10/1/e003488.full
spellingShingle Laetitia Fend
Eric Quemeneur
Monika Semmrich
Jean-Baptiste Marchand
Matilda Rehn
Nathalie Silvestre
Linda Mårtensson
Johann Foloppe
Ingrid Teige
Björn Frendeus
Petra Holmkvist
Carolin Svensson
Christelle Remy
Patricia Kleinpeter
Jules Deforges
Fred Junghus
Kirstie L Cleary
Mimoza Bodén
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors
Journal for ImmunoTherapy of Cancer
title Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors
title_full Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors
title_fullStr Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors
title_full_unstemmed Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors
title_short Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors
title_sort vectorized treg depleting αctla 4 elicits antigen cross presentation and cd8 t cell immunity to reject cold tumors
url https://jitc.bmj.com/content/10/1/e003488.full
work_keys_str_mv AT laetitiafend vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT ericquemeneur vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT monikasemmrich vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT jeanbaptistemarchand vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT matildarehn vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT nathaliesilvestre vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT lindamartensson vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT johannfoloppe vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT ingridteige vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT bjornfrendeus vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT petraholmkvist vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT carolinsvensson vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT christelleremy vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT patriciakleinpeter vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT julesdeforges vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT fredjunghus vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT kirstielcleary vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors
AT mimozaboden vectorizedtregdepletingactla4elicitsantigencrosspresentationandcd8tcellimmunitytorejectcoldtumors